Table 3.
Dataset | References | BL: HR vs. HV |
Time: HR vs. HV |
Time: CHR-T vs. CHR-NT |
BL: Predict Transition |
Significant brain regions for HR vs. HV over time | Significant brain regions for CHR-T vs. CHR-NT over time | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Whole brain | Frontal | ACC | Temporal | Parietal | Occipital | Thalamus | Amygdala | Basal Ganglia | Cerebellum | Ventricle | Whole brain | Frontal | Insula | ACC | Temporal | Parietal | Occipital | Nucleus Accumbens | Cerebellum | Ventricle | ||||||
Toho University | Katagiri et al. (15) | NA | NA | NA | ||||||||||||||||||||||
ADAPT | Damme et al. (16) | NA | NA | |||||||||||||||||||||||
NAPLS | Cannon et al. (17) | NA | NA | ↓ CT | ↑ Vol | |||||||||||||||||||||
Chung et al. (18) | NA | NA | NA | NA | ||||||||||||||||||||||
Chung et al. (19) | NA | NA | NA | NA | ||||||||||||||||||||||
Singapore | Ho et al. (20) | NA | NA | ↓ Vol | ||||||||||||||||||||||
NIMH COS Study | Gogtay et al. (21) | NA | NA | ↓ CT | ↓ CT | ↓ CT | ||||||||||||||||||||
Mattai et al. (22) | NA | NA | ↓ CT | ↓ CT | ↓ CT | |||||||||||||||||||||
Zalesky et al. (23) | NA | NA | NA | ↓ Con | ↓ Con | |||||||||||||||||||||
Greenstein et al. (24) | NA | NA | ↓ Vol | |||||||||||||||||||||||
Mattai (25) | NA | NA | ||||||||||||||||||||||||
Sibling pair, Utrecht | Brans et al. (26) | NA | NA | NA | ||||||||||||||||||||||
Twin pair, Utrecht | Hedman et al. (27) | NA | NA | NA | ↓ CT | ↓ CT | ||||||||||||||||||||
Dutch Prediction Psychosis | Ziermans et al. (28) | ↓ CT | ↓ Vol | ↓ CT | ↓ CT | ↓ CT | ↓ CT | |||||||||||||||||||
de Wit et al. (29) | NA | NA | ↔ SA | ↔ SA ↑ Vol |
↓ SA |
↓ Vol ↓ CT |
↔ SA ↓ GI |
↓ SA ↓ GI ↓ Vol | ↓ Vol |
↑ Vol | ↓ CT* SA* | ↓ Vol*↓ CT* ↓ SA |
↓ Vol ↑ GI |
↓ Vol*↓ CT*↔ CT | ↓ Vol*↓ CT* |
↓ Vol* |
↑ Vol | |||||||||
Edinburgh High Risk Study | Lawrie et al. (30) | NA | ↓ Vol | |||||||||||||||||||||||
Job et al. (31) | NA | Effect of time | Effect of time | NA | ↓ Vol | ↓ Vol | ↓ Vol | ↓ Vol | ||||||||||||||||||
Mcintosh et al. (32) | ↓ Vol | ↓ Vol | ↓ Vol | ↓ Vol | ||||||||||||||||||||||
Bois et al. (33) | ↓ CT, ↔ SA |
↓ CT | ↓ CT | ↔ CT | ||||||||||||||||||||||
Bois et al. (34) | NA | NA | ↔ Vol | |||||||||||||||||||||||
Edinburgh Study of Comorbidity | Moorhead et al. (35) | NA | NA | NA | ↓ Vol | ↓ Vol | ||||||||||||||||||||
McKechanie et al. (36) | NA | NA | NA | NA | ||||||||||||||||||||||
FEPSY project | Walter et al. (37) | NA | NA | |||||||||||||||||||||||
Walter et al. (38) | NA | NA | NA | |||||||||||||||||||||||
Borgwardt et al. (39) | NA | NA | ↓ Vol | ↓ Vol | ↓ Vol | ↓ Vol | ||||||||||||||||||||
OASIS | Fusar-Poli et al. (40) | Effect of time | Effect of time | ↑↓ Vol | ↑ Vol | ↓ Vol | ↑ Vol | ↓ Vol | ||||||||||||||||||
PACE | Pantelis et al. (41) | NA | NA | Effect of time | ↓ Vol | ↓ Vol | ↓ Vol | ↑ Vol | ↓ Vol | |||||||||||||||||
Sun et al. (42) | NA | NA | NA | ↓ SA | ||||||||||||||||||||||
Takahashi et al. (43) | NA | NA | ↓ Vol | |||||||||||||||||||||||
Takahashi et al. (44) | NA | NA | ↓ Vol | |||||||||||||||||||||||
Ludwig Maximilians | Koutsouleris et al. (45) | NA | ↓ Vol | ↓ Vol | ↓ Vol | ↓ Vol | ↓ Vol | ↓ Vol | ↓ Vol | ↑ Vol | ↓ Vol | ↓ Vol | ↑ Vol | |||||||||||||
Western Psychiatric Institute and Clinic | Bhojraj et al. (46) | NA | NA | NA | ↓ SA | |||||||||||||||||||||
Bhojraj et al. (47) | NA | ↓ Vol | ↓ Vol | ↓ Vol | ||||||||||||||||||||||
Prasad et al. (48) | NA | NA | ↓ SA | ↓ SA, ↓ Vol, ↑ CT | ↓ Vol, ↑ CT | ↓ Vol, ↑ CT | ↓ SA, ↓ Vol | |||||||||||||||||||
IMAGEN | Yu et al. (49) | NA | NA | NA | ↔ Vol | |||||||||||||||||||||
Dublin & Kildare | Calvo et al. (50) | Effect of group | NA | NA | ↓ Vol* | |||||||||||||||||||||
Barcelona | Sugranyes et al. (51) | NA | NA | ↔ SA | ||||||||||||||||||||||
Sugranyes et al. (52) | NA | NA | ↓ CT ↓ SA* NT vs. HV: ↔ SA+Vol | ↓ CT | ||||||||||||||||||||||
TOTAL: | 9/14 | 20/24 | 15/19 | 9/15 | 6 | 9 | 6 | 16 | 6 | 4 | 1 | 1 | 2 | 4 | 2 | 3 | 6 | 1 | 4 | 9 | 4 | 3 | 1 | 3 | 3 | |
BL: HR vs. HV |
Time: HR vs. HV | Time: CHR-T vs. CHR-NT | BL: Predict Transition | Whole brain | Frontal | ACC | Temporal | Parietal | Occipital | Thalamus | Amygdala | Basal Ganglia | Cerebellum | Ventricle | Whole brain | Frontal | Insula | ACC | Temporal | Parietal | Occipital | Nucleus Accumbens | Cerebellum | Ventricle |
Arrows indicate altered trajectories between groups in specified brain region, ↓ indicate a decrease in the HR or CHR-T group compared to HV or CHR-NT respectively, ↑ indicate an increase and ↔ indicate no change over time in HR whereas an increase/decrease is seen in HV. HR, high risk; HV, healthy volunteer; CHR-T, clinical high risk transition; CHR-NT, no transition; ACC, Anterior cingulate cortex; NA, Not Applicable (for example studies examine other contrasts such as medicated vs. unmedicated); CT, cortical thickness; Vol, gray matter volume; Conn, structural connectivity; SA, surface area; GI, gyrification.
volume was lower in HR vs. HV at both timepoints but there was no group × time interaction.